Retatrutide is an experimental triple-receptor agonist peptide that has gained attention for its significant role in fat loss, appetite suppression, and metabolic optimization. By acting on GLP-1, GIP, and glucagon receptors, it provides a multi-pronged approach to improving metabolic health.
Mechanism of Action:
Retatrutide stimulates multiple gut hormone receptors, leading to:
-
Delayed gastric emptying
-
Increased insulin sensitivity
-
Suppressed appetite and caloric intake
-
Enhanced fat oxidation
Research Highlights:
Early clinical trials have shown promising outcomes in body weight reduction and improved glucose regulation. It’s being studied for potential superiority over single agonists like semaglutide.
Product Tie-In:
[Retatrutide 10mg – $119.99]
For laboratory research focused on metabolic disease models and weight loss pathways.
For research use only.
